ClinicalTrials.gg
Status unknownNCT06553105Updated Aug 14, 2024

Diagnosis and Clinical Presentation of Iliac Graft-Enteric Fistula: A Case Report

An observational study in Case-report, Diagnosis and Digestive System Fistula, sponsored by Golestan University of Medical sciences. Status unknown. Open to male participants aged 40 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-14.

Sponsored by Golestan University of Medical sciences · Observational

The sponsor has not verified this record recently (last verified Aug 2024), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Other
Enrollment
1
Ages
40 Years to 50 Years
Sex
Male
01

Study summary

Abstract

Introduction:

Aorto-enteric fistula (AEF) is a life-threatening complication arising from abnormal connections between the gastrointestinal tract and major arteries. One uncommon type, iliac artery-enteric fistula (IEF), can occur following vascular interventions such as arterial stent-graft placement.

Case Presentation:

We report the case of a 47-year-old male presenting with hematemesis and abdominal pain, who was diagnosed with an iliac graft-enteric fistula. Timely recognition and management were crucial for a favorable outcome.

Clinical Discussion:

Diagnosing AEFs remains challenging, requiring a multidisciplinary approach and high clinical suspicion. While computed tomography angiography (CTA) is commonly used for diagnosis, its sensitivity may be limited, emphasizing the importance of integrating clinical history and findings. Management strategies vary based on etiology and patient status, with surgery being pivotal.

Conclusion:

Aorto-enteric fistula, which can arise from a thrombosed graft, presents diagnostic challenges due to its rare formation. In patients with a history of vascular interventions and gastrointestinal bleeding, AEF should be considered. This case underscores the need for heightened awareness among healthcare professionals regarding AEF diagnosis and management to reduce severe morbidity, mortality, and prolonged hospital stays.

02

Conditions studied

  • Case-report
  • Diagnosis
  • Digestive System Fistula
  • Gastrointestinal Hemorrhage
  • Iliac Graft-Enteric Fistula

Keywords

  • case-report; CT scan; Diagnosis; Digestive System Fistula; Gastrointestinal Hemorrhage; Iliac Graft-Enteric Fistula.
03

In context

Disease

1,382 studies on the registry are indexed under Disease; 612 are open to participants now.

This study's planned enrollment of 1 is below the median of 209 across 598 observational studies indexed under Disease.

Browse Disease studies →

Lead sponsor

Golestan University of Medical sciences is the lead sponsor of 9 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 50 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

one man

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

n/a

Exclusion criteria

Exclusion Criteria:

n/a

05

Study design

Observational model
Case-only
Time perspective
Other
Enrollment
1 participant (estimated)
Target follow-up
10 Days
Patient registry
Yes

Interventions

  • Diagnostic testct scan

    use ct scan for diagnosis fistula

06

What researchers measure

Primary outcomes

  1. diagnosis of fistula by ct scan

    Time frame: one day

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 14, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06553105
Lead sponsor
Golestan University of Medical sciences
Responsible party
Reza zahedpasha (Department of Radiology, School of Medicine, 5th Azar Hospital, Gorgan, Golestan, Iran, Golestan University of Medical sciences) — Principal investigator
First posted
Aug 14, 2024
Start date
Aug 11, 2024 (estimated)
Primary completion
Aug 12, 2024 (estimated)
Completion
Aug 13, 2024 (estimated)
Last update
Aug 14, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion